
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
SSE:603392.SS
64.14 (CNY) • At close June 17, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||
Current Assets: | ||||||||||||
Cash & Cash Equivalents
| 2,387.853 | 3,818.319 | 5,192.248 | 1,415.316 | 710.666 | 283.601 | 427.036 | 340.045 | 308.043 | 320.734 | 272.882 | 133.279 |
Short Term Investments
| 2,510.052 | 2,455.361 | 2,008.613 | 40.389 | 50.361 | 58.001 | 0.344 | 0.671 | 0.62 | 0.301 | 0.064 | 0.122 |
Cash and Short Term Investments
| 4,897.905 | 6,273.68 | 7,200.861 | 1,455.705 | 761.027 | 341.602 | 427.38 | 340.716 | 308.663 | 321.035 | 272.947 | 133.401 |
Net Receivables
| 2,077.2 | 2,998.983 | 3,960.01 | 2,276.695 | 711.602 | 284.702 | 192.823 | 195.369 | 170.996 | 135.04 | 122.018 | 114.347 |
Inventory
| 863.193 | 905.485 | 869.137 | 593.167 | 400.037 | 236.434 | 218.642 | 178.706 | 151.964 | 105.52 | 85.462 | 76.897 |
Other Current Assets
| 536.578 | 123.927 | 149.752 | 321.034 | 105.123 | 70.89 | 31.739 | 45.139 | 22.94 | 23.357 | 20.279 | 38.68 |
Total Current Assets
| 8,374.875 | 10,302.075 | 12,179.759 | 4,646.602 | 1,977.79 | 885.659 | 870.584 | 759.93 | 654.563 | 584.952 | 500.706 | 363.324 |
Non-Current Assets: | ||||||||||||
Property, Plant & Equipment, Net
| 3,538.197 | 2,882.554 | 2,235.293 | 1,702.886 | 790.977 | 627.703 | 584.526 | 570.551 | 354.023 | 269.917 | 210.753 | 158.476 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.644 | 4.644 | 4.644 | 0 | 0 |
Intangible Assets
| 712.864 | 642.745 | 332.376 | 295.127 | 233.947 | 242.031 | 248.872 | 253.902 | 263.053 | 193.401 | 55.077 | 56.313 |
Goodwill and Intangible Assets
| 712.864 | 642.745 | 332.376 | 295.127 | 233.947 | 242.031 | 248.872 | 258.546 | 267.698 | 198.045 | 55.077 | 56.313 |
Long Term Investments
| -1,148.043 | 1,432.01 | -1,097.317 | 20.907 | 160.934 | 170.5 | 17.563 | 15.151 | 4.685 | 4.74 | 18.045 | 17.346 |
Tax Assets
| 243.333 | 157.955 | 66.005 | 68.97 | 56.494 | 93.688 | 64.036 | 24.097 | 26.334 | 15.413 | 12.262 | 8.928 |
Other Non-Current Assets
| 2,968.17 | 297.66 | 2,513.401 | 311.456 | 283.537 | 145.338 | 29.083 | 27.517 | 147.16 | 28.552 | 8.662 | 2.591 |
Total Non-Current Assets
| 6,314.521 | 5,412.923 | 4,049.757 | 2,399.346 | 1,525.889 | 1,279.26 | 944.081 | 895.862 | 799.9 | 516.668 | 304.798 | 243.654 |
Total Assets
| 14,689.396 | 15,714.998 | 16,229.517 | 7,045.948 | 3,503.679 | 2,164.92 | 1,814.665 | 1,655.792 | 1,454.462 | 1,101.619 | 805.505 | 606.978 |
Liabilities & Equity: | ||||||||||||
Current Liabilities: | ||||||||||||
Account Payables
| 444.862 | 299.868 | 317.038 | 193.455 | 112.738 | 85.047 | 74.44 | 86.643 | 52.324 | 50.484 | 27.95 | 32.08 |
Short Term Debt
| 103.624 | 168.33 | 140.139 | 1,371.955 | 77.656 | 0 | 0 | 100 | 0 | 0 | 31 | 30 |
Tax Payables
| 23.504 | 7.489 | 145.004 | 189.685 | 13.909 | 11.609 | 13.903 | 5.994 | 8.309 | 15.373 | 10.004 | 13.314 |
Deferred Revenue
| 0 | 0 | 82.279 | 1,920.385 | 635.731 | 121.062 | 38.693 | 361.013 | 0 | 237.537 | 98.255 | 105.677 |
Other Current Liabilities
| 1,440.081 | 2,194.288 | 2,883.009 | 1,676.652 | 583.8 | 395.375 | 255.949 | 17.489 | 360.549 | 237.623 | 1.425 | 101.698 |
Total Current Liabilities
| 2,012.072 | 2,669.975 | 3,485.19 | 2,365.729 | 829.026 | 492.031 | 344.292 | 571.138 | 421.182 | 303.48 | 168.634 | 177.092 |
Non-Current Liabilities: | ||||||||||||
Long Term Debt
| 175.168 | 127.719 | 120.915 | 37.492 | 18.347 | 21 | 21 | 118.346 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 54.197 | 0 | 41.369 | 76.436 | 94.26 | 71.16 | 78.946 | 67.315 | 73.576 | 73.449 | 56.318 | 47.594 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 17.151 | 0 | 0 | -21 | -21 | -118.346 | 0 | 0 | -56.318 | -47.594 |
Other Non-Current Liabilities
| 0 | 33.647 | 0 | 80.236 | 4.897 | 71.16 | 0 | 67.315 | 0 | 75.449 | 0 | 0.234 |
Total Non-Current Liabilities
| 229.365 | 161.366 | 179.435 | 117.728 | 94.26 | 92.16 | 99.946 | 185.662 | 73.576 | 75.449 | 56.552 | 47.828 |
Total Liabilities
| 2,241.436 | 2,831.341 | 3,664.625 | 2,483.457 | 923.286 | 584.19 | 444.237 | 756.8 | 494.758 | 378.929 | 225.186 | 224.92 |
Equity: | ||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 1,265.123 | 1,268.207 | 906.071 | 607.04 | 433.6 | 390 | 390 | 361.2 | 361.2 | 361.2 | 86 | 82.5 |
Retained Earnings
| 7,231.873 | 7,574.801 | 7,357.056 | 3,151.075 | 1,446.089 | 799.427 | 612.839 | 349.421 | 242.867 | 145.163 | 326.372 | 220.349 |
Accumulated Other Comprehensive Income/Loss
| 0 | 696.604 | 571.755 | 284.162 | 249.966 | 219.631 | 197.354 | 167.705 | 0 | -0 | 0 | -0 |
Other Total Stockholders Equity
| 3,765.807 | 3,160.986 | 3,506.376 | 424.01 | 424.01 | 172.023 | 149.762 | -189.963 | 284.987 | 107.887 | 167.946 | 79.209 |
Total Shareholders Equity
| 12,262.802 | 12,700.598 | 12,341.257 | 4,466.287 | 2,553.665 | 1,558.82 | 1,349.955 | 878.328 | 889.055 | 689.942 | 580.318 | 382.058 |
Total Equity
| 12,447.96 | 12,883.657 | 12,564.892 | 4,562.491 | 2,580.393 | 1,580.729 | 1,370.428 | 898.992 | 959.704 | 722.69 | 580.318 | 382.058 |
Total Liabilities & Shareholders Equity
| 14,689.396 | 15,714.998 | 16,229.517 | 7,045.948 | 3,503.679 | 2,164.92 | 1,814.665 | 1,655.792 | 1,454.462 | 1,101.619 | 805.505 | 606.978 |